Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Aline Teotonio
Data de Publicação: 2017
Outros Autores: Stahlschmidt, Rebeca, Granja, Silvia, Pilger, Diogo, Falcão, Antonio Luis Eiras, Mazzola, Priscila Gava
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/131435
Resumo: Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results.
id USP-31_ed9339f8e7adfc15fabe0c22fc83e33a
oai_identifier_str oai:revistas.usp.br:article/131435
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospitalPotential drug-drug interactionsIntensive care unitPatient safetyUniversity hospitals.Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2017-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/13143510.1590/s2175-97902017000116109Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e16109-Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e16109-Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e16109-2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/131435/127815Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)info:eu-repo/semantics/openAccessRodrigues, Aline TeotonioStahlschmidt, RebecaGranja, SilviaPilger, DiogoFalcão, Antonio Luis EirasMazzola, Priscila Gava2017-04-20T20:28:50Zoai:revistas.usp.br:article/131435Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2017-04-20T20:28:50Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
title Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
spellingShingle Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
Rodrigues, Aline Teotonio
Potential drug-drug interactions
Intensive care unit
Patient safety
University hospitals.
title_short Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
title_full Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
title_fullStr Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
title_full_unstemmed Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
title_sort Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital
author Rodrigues, Aline Teotonio
author_facet Rodrigues, Aline Teotonio
Stahlschmidt, Rebeca
Granja, Silvia
Pilger, Diogo
Falcão, Antonio Luis Eiras
Mazzola, Priscila Gava
author_role author
author2 Stahlschmidt, Rebeca
Granja, Silvia
Pilger, Diogo
Falcão, Antonio Luis Eiras
Mazzola, Priscila Gava
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Rodrigues, Aline Teotonio
Stahlschmidt, Rebeca
Granja, Silvia
Pilger, Diogo
Falcão, Antonio Luis Eiras
Mazzola, Priscila Gava
dc.subject.por.fl_str_mv Potential drug-drug interactions
Intensive care unit
Patient safety
University hospitals.
topic Potential drug-drug interactions
Intensive care unit
Patient safety
University hospitals.
description Patients in intensive care unit are prescribed large numbers of drugs, highlighting the need to study potential Drug-Drug Interactions in this environment. The aim of this study was to delineate the prevalence and risk of potential drug-drug interactions between medications administered to patients in an ICU. This cross-sectional observational study was conducted during 12 months, in an adult ICU of a teaching hospital. Inclusion criteria were: prescriptions with 2 or more drugs of patients admitted to the ICU for >; 24 hours and age of ≥18 years. Potential Drug-Drug Interactions were quantified and classified through MicromedexTM database. The 369 prescriptions included in this study had 205 different drugs, with an average of 13.04 ± 4.26 (mean ± standard deviation) drugs per prescription. Potential Drug-Drug Interactions were identified in 89% of these, with an average of 5.00 ± 5.06 interactions per prescription. Of the 405 different pairs of potentially interacting drugs identified, moderate and major interactions were present in 74% and 67% of prescriptions, respectively. The most prevalent interaction was between dipyrone and enoxaparin (35.8%), though its clinical occurrence was not observed in this study. The number of potential Drug-Drug Interactions showed significant positive correlations with the length of stay in the intensive care unit, and with the number of prescribed drugs. Acknowledging the high potential for Drug-Drug Interactions in the ICU represents an important step toward improving patient safety and best therapy results.
publishDate 2017
dc.date.none.fl_str_mv 2017-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/131435
10.1590/s2175-97902017000116109
url https://www.revistas.usp.br/bjps/article/view/131435
identifier_str_mv 10.1590/s2175-97902017000116109
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/131435/127815
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences (Impresso)
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 53 Núm. 1 (2017); e16109-
Brazilian Journal of Pharmaceutical Sciences; v. 53 n. 1 (2017); e16109-
Brazilian Journal of Pharmaceutical Sciences; Vol. 53 No. 1 (2017); e16109-
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913210613760